Up to the three most likely bone age results with the highest
probabilities are presented by the software according to the most similar age groups (male: 31 groups, female: 27 groups) defined by the GP (Greulich-Pyle) method.
All doctors have to do is to click the most probable one among the top three options provided by the solution, being spared the time-consuming job of sifting through a reference book.
By providing detailed bone age results on a monthly basis through not only G.P. Atlas but also AI-based bone age results (VUNO Score), it assists in more accurate reading.
• The performance of the BoneAge software was validated by external clinical studies.
When implemented for a second opinion in daily clinical practice, radiologists' reading times were reduced by 29% on average without compromising the accuracy of bone age estimation.
Reading times were reduced by 18.0% and 40.0% for reviewers.
In addition to reading time reduction, VUNO Med-BoneAge improves reading consistency among doctors by more than 13%.
These concordance rates increased with the use of the product for both reviewer 1 (from 63.0% to 72.5%) and reviewer 2 (from 49.5% to 57.5%)
Almost all cases (93%) were within the Top 3 results suggested by VUNO Med®-BoneAge™ and 69.5% cases were Top 1.
• Provides analytic information on whether the patient is within the normal range based on the BoneAge™ results and chronological age
• Easy to explain to patients as the report provides a visual graph on projected final height based on the results and patient information such as age, current height and gender
• Two types of reports: A short summary with analysis results only and a comprehensive report including all related information on height projection
AI system to assist clinicians detect and diagnose prostate cancer.
Brain Stimulation Simulation Software
AI for lung nodule detection and analysis
Enhancing COPD Management through AI-Powered Analysis
